Seres Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $11k | 8.1k | 1.40 |
| 2023-09-30 | $395k | 166k | 2.38 |
| 2023-06-30 | $351k | 73k | 4.79 |
| 2023-03-31 | $624k | 110k | 5.67 |
| 2022-12-31 | $1.2M | 221k | 5.60 |
| 2022-09-30 | $227k | 36k | 6.36 |
| 2022-06-30 | $12k | 3.6k | 3.31 |
| 2022-03-31 | $663k | 94k | 7.06 |
| 2021-12-31 | $39k | 4.7k | 8.37 |
| 2021-09-30 | $2.7M | 396k | 6.94 |
| 2021-06-30 | $170k | 8.0k | 21.28 |
| 2021-03-31 | $168k | 8.2k | 20.52 |
| 2020-12-31 | $44k | 1.8k | 24.44 |
| 2020-09-30 | $255k | 9.0k | 28.36 |
| 2020-06-30 | $3.0k | 700 | 4.29 |
| 2020-03-31 | $45k | 13k | 3.55 |
| 2019-12-31 | $151k | 40k | 3.75 |
| 2019-09-30 | $88k | 22k | 3.99 |
| 2019-06-30 | $4.0k | 1.3k | 3.08 |
| 2019-03-31 | $14k | 2.0k | 7.00 |
| 2018-12-31 | $16k | 3.2k | 5.00 |
| 2018-09-30 | $6.0k | 800 | 7.50 |
| 2018-06-30 | $24k | 2.8k | 8.57 |
| 2018-03-31 | $15k | 2.1k | 7.14 |
| 2017-12-31 | $26k | 2.6k | 10.00 |
| 2017-09-30 | $42k | 2.6k | 16.15 |
| 2017-06-30 | $57k | 5.1k | 11.15 |
| 2017-03-31 | $60k | 5.3k | 11.22 |
| 2016-12-31 | $31k | 3.1k | 10.03 |
| 2016-09-30 | $49k | 4.0k | 12.28 |
| 2016-06-30 | $50k | 1.8k | 28.41 |
| 2016-03-31 | $50k | 1.9k | 26.52 |
| 2015-12-31 | $38k | 1.1k | 35.55 |